SSA
ASLN

Schonfeld Strategic Advisors’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,538
Closed -$37.3K – 2567
2024
Q2 		$37.3K Sell
15,538
-2,887
-16% -$10.2K ﹤0.01% 1962
2024
Q1 		$90.7K Buy
18,425
+14,962
+432% +$75K ﹤0.01% 1858
2023
Q4 		$14.5K Sell
3,463
-7,975
-70% -$60.2K ﹤0.01% 1707
2023
Q3 		$172K Buy
11,438
+4,638
+68% +$85.1K ﹤0.01% 1439
2023
Q2 		$199K Buy
+6,800
New +$210K ﹤0.01% 1575
2021
Q3 		– Sell
-1,138
Closed -$150K – 2553
2021
Q2 		$150K Sell
1,138
-122
-10% -$15.3K ﹤0.01% 1739
2021
Q1 		$168K Buy
+1,260
New +$160K ﹤0.01% 1560

Other funds holding ASLN

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Schonfeld Strategic Advisors's ASLN Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 15,538 shares — an estimated $37.3K sold.

Schonfeld Strategic Advisors first reported a position in ASLN in Q1 2021 and held it in 7 quarters. The position peaked at $199K in Q2 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 15,538 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $37.3K.
  • Schonfeld Strategic Advisors first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $199K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.